Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma

Archives of Ophthalmology

Volumn 129, Issue 10, 2011, Pages 1337-1344

  Ebneter, Andreas ^a   Chidlow, Glyn ^a   Wood, John P M ^a   Casson, Robert J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CORNEA LIMBUS; DISEASE ASSOCIATION; GLAUCOMA; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LASER; MICROGLIA; NERVE FIBER; NERVE FIBER DEGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; OPTIC NERVE DISEASE; PERIKARYON; PRIORITY JOURNAL; RAT; RETINA; RETINA GANGLION CELL; RETINA INJURY;

ANIMALS; AXONS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CELL COUNT; CELL SURVIVAL; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; NERVE DEGENERATION; NERVE TISSUE PROTEINS; OCULAR HYPERTENSION; OPTIC NERVE DISEASES; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS; TONOMETRY, OCULAR;

EID: 80053892558     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.269     Document Type: Article

References (40)

1. Burgoyne CF, Morrison JC. The anatomy and pathophysiology of the optic nerve head in glaucoma. J Glaucoma. 2001;10(5)(suppl 1):S16-S18.
2. Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21(4):359-393. (Pubitemid 34879080)
3. Osborne NN, Chidlow G, Layton CJ, Wood JP, Casson RJ, Melena J. Optic nerve and neuroprotection strategies. Eye (Lond). 2004;18(11):1075-1084. (Pubitemid 39591789)
4. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study, II: association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol. 1977;106(1):33-41. (Pubitemid 8160456)
5. Leske MC, Connell AM, Wu SY, Hyman LG, Schachat AP. Risk factors for open-angle glaucoma: the Barbados Eye Study. Arch Ophthalmol. 1995;113(7):918-924.
6. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology. 1995;102(1):48-53.
7. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes: the Beaver Dam Eye Study. Ophthalmology. 1994;101(7):1173-1177. (Pubitemid 24236073)
8. Chopra V, Varma R, Francis BA, Wu J, Torres M, Azen SP; Los Angeles Latino Eye Study Group. Type 2 diabetes mellitus and the risk of open-angle glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008;115(2):227-232, e1.
9. Mitchell P, Smith W, Chey T, Healey PR. Open-angle glaucoma and diabetes: the Blue Mountains Eye Study, Australia. Ophthalmology. 1997;104(4):712-718. (Pubitemid 27171997)
10. Krueger RR, Ramos-Esteban JC. How might corneal elasticity help us understand diabetes and intraocular pressure? J Refract Surg. 2007;23(1):85-88. (Pubitemid 46122701)
11. Castro DP, Prata TS, Lima VC, Biteli LG, de Moraes CG, Paranhos A Jr. Corneal viscoelasticity differences between diabetic and nondiabetic glaucomatous patients. J Glaucoma. 2010;19(5):341-343.
12. Su DH, Wong TY, Wong WL, et al Singapore Malay Eye Study Group. Diabetes, hyperglycemia, and central corneal thickness: the Singapore Malay Eye Study. Ophthalmology. 2008;115(6):964-968, e1. doi:10.1016/j.ophtha.2007.08.021.
13. Broman AT, Congdon NG, Bandeen-Roche K, Quigley HA. Influence of corneal structure, corneal responsiveness, and other ocular parameters on tonometric measurement of intraocular pressure. J Glaucoma. 2007;16(7):581-588. (Pubitemid 350307608)
14. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701-713, 829-830.
15. Medeiros FA, Weinreb RN, Sample PA, et al. Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma. Arch Ophthalmol. 2005;123(10):1351-1360. (Pubitemid 41429735)
16. Quigley HA. Can diabetes be good for glaucoma? why can't we believe our own eyes (or data)? Arch Ophthalmol. 2009;127(2):227-229.
17. Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol. 2001;58(8):1209-1212. (Pubitemid 32751739)
18. Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord. 2008;9(4):315-327.
19. Tomlinson DR, Gardiner NJ. Glucose neurotoxicity. Nat Rev Neurosci. 2008;9(1):36-45. (Pubitemid 350295687)
20. Casson RJ, Chidlow G, Wood JP, Osborne NN. The effect of hyperglycemia on experimental retinal ischemia. Arch Ophthalmol. 2004;122(3):361-366. (Pubitemid 38314198)
21. Holman MC, Chidlow G, Wood JP, Casson RJ. The effect of hyperglycemia on hypoperfusion- induced injury. Invest Ophthalmol Vis Sci. 2010;51(4):2197-2207.
22. Casson RJ, Wood JP, Osborne NN. Hypoglycaemia exacerbates ischaemic retinal injury in rats. Br J Ophthalmol. 2004;88(6):816-820. (Pubitemid 38725594)
23. Wood JP, Chidlow G, Graham M, Osborne NN. Energy substrate requirements for survival of rat retinal cells in culture: the importance of glucose and monocarboxylates. J Neurochem. 2005;93(3):686-697. (Pubitemid 40617628)
24. Melena J, Safa R, Graham M, Casson RJ, Osborne NN. The monocarboxylate transport inhibitor, alpha-cyano-4-hydroxycinnamate, has no effect on retinal ischemia. Brain Res. 2003;989(1):128-134. (Pubitemid 37281410)
25. Ebneter A, Casson RJ, Wood JP, Chidlow G. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci. 2010;51(12):6448- 6460.
26. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest. 1998;102(4):783-791. (Pubitemid 28399611)
27. Levkovitch-Verbin H, Quigley HA, Martin KR, Valenta D, Baumrind LA, Pease ME. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci. 2002;43(2):402-410. (Pubitemid 34113222)
28. Marina N, Bull ND, Martin KR. A semiautomated targeted sampling method to assess optic nerve axonal loss in a rat model of glaucoma. Nat Protoc. 2010;5(10):1642-1651.
29. Pease ME, Zack DJ, Berlinicke C, et al. Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. Invest Ophthalmol Vis Sci. 2009;50(5):2194-2200.
30. Meller D, Eysel UT, Schmidt-Kastner R. Transient immunohistochemical labelling of rat retinal axons during Wallerian degeneration by a monoclonal antibody to neurofilaments. Brain Res. 1994;648(1):162-166. (Pubitemid 24171586)
31. Chidlow G, Holman MC, Wood JP, Casson RJ. Spatiotemporal characterization of optic nerve degeneration after chronic hypoperfusion in the rat. Invest Ophthalmol Vis Sci. 2010;51(3):1483-1497.
32. Buckingham BP, Inman DM, Lambert W, et al. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci. 2008;28(11):2735-2744.
33. Canola K, Angénieux B, Tekaya M, et al. Retinal stem cells transplanted into models of late stages of retinitis pigmentosa preferentially adopt a glial or a retinal ganglion cell fate. Invest Ophthalmol Vis Sci. 2007;48(1):446-454.
34. Zhong L, Bradley J, Schubert W, et al. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci. 2007;48(3):1212-1218. (Pubitemid 351261416)
35. Kalesnykas G, Niittykoski M, Rantala J, et al. The expression of heat shock protein 27 in retinal ganglion and glial cells in a rat glaucoma model. Neuroscience. 2007;150(3):692-704. (Pubitemid 350198739)
36. O'Reilly AM, Currie RW, Clarke DB. HspB1 (Hsp 27) expression and neuroprotection in the retina. Mol Neurobiol. 2010;42(2):124-132.
37. van Rijk AF, Bloemendal H. Alpha-B-crystallin in neuropathology. Ophthalmologica. 2000;214(1):7-12. (Pubitemid 30084876)
38. Kanamori A, Nakamura M, Mukuno H, Maeda H, Negi A. Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure. Curr Eye Res. 2004;28(1):47-54. (Pubitemid 38161173)
39. Baltan S, Inman DM, Danilov CA, Morrison RS, Calkins DJ, Horner PJ. Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration. J Neurosci. 2010;30(16):5644-5652.
40. Terada M, Yasuda H, Kikkawa R. Delayed Wallerian degeneration and increased neurofilament phosphorylation in sciatic nerves of rats with streptozocin-induced diabetes. J Neurol Sci. 1998;155(1):23-30. (Pubitemid 28141054)